What does PHARMACIE CENTRALE DE BRAINE L'ALLEUD do?

PHARMACIE CENTRALE DE BRAINE L'ALLEUD is a pharmacy in Braine-l'Alleud. Public Limited, started on 16 October 1989, 1 establishment.

What is the address of PHARMACIE CENTRALE DE BRAINE L'ALLEUD?

The registered office of PHARMACIE CENTRALE DE BRAINE L'ALLEUD is located at Avenue Léon Jourez 2, 1420 Braine-l'Alleud.

Is PHARMACIE CENTRALE DE BRAINE L'ALLEUD still active?

Yes. According to the CBE (29 October 2026) PHARMACIE CENTRALE DE BRAINE L'ALLEUD is active, legal situation “Normale toestand”, started on 16 October 1989.

Is PHARMACIE CENTRALE DE BRAINE L'ALLEUD registered on Peppol?

Yes, PHARMACIE CENTRALE DE BRAINE L'ALLEUD is registered on the Peppol network with ID 0208:0438709422.

What is the enterprise number of PHARMACIE CENTRALE DE BRAINE L'ALLEUD?

The enterprise number of PHARMACIE CENTRALE DE BRAINE L'ALLEUD is BE0438709422.

When was PHARMACIE CENTRALE DE BRAINE L'ALLEUD founded?

PHARMACIE CENTRALE DE BRAINE L'ALLEUD was founded on 16 October 1989.

Who are the directors of PHARMACIE CENTRALE DE BRAINE L'ALLEUD?

According to the 2025 annual accounts, the directors of PHARMACIE CENTRALE DE BRAINE L'ALLEUD are: Jean-Philippe Leroy, ORELYS SRL.

Is PHARMACIE CENTRALE DE BRAINE L'ALLEUD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 October 1989; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE CENTRALE DE BRAINE L'ALLEUD make in 2025?

PHARMACIE CENTRALE DE BRAINE L'ALLEUD posted a profit after taxes of € 22,977 in financial year 2025.

What is the revenue of PHARMACIE CENTRALE DE BRAINE L'ALLEUD?

As a small company, PHARMACIE CENTRALE DE BRAINE L'ALLEUD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 617,583.

How much does an employee at PHARMACIE CENTRALE DE BRAINE L'ALLEUD earn?

The average wage cost per full-time employee at PHARMACIE CENTRALE DE BRAINE L'ALLEUD was € 53,200 in 2023: staff costs of € 250,083 for 4.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

PHARMACIE CENTRALE DE BRAINE L'ALLEUD (Public Limited)

Dossier PHARMACIE CENTRALE DE BRAINE L'ALLEUD, printed on 29 October 2026 from databakkes.be/en/0438709422/pharmacie-centrale-de-braine-l-alleud. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 36 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE CENTRALE DE BRAINE L'ALLEUD from Braine-l'Alleud, company number BE0438709422, closed financial year 2025 with a result of € 22,977 after tax. For that financial year PHARMACIE CENTRALE DE BRAINE L'ALLEUD recorded a gross margin of € 617,583 and equity of € -312,085. Compared with financial year 2024, the result moved from € 28,970 to € 22,977. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Caution

€ -312,085

▲ € 22,977 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 22,977

▼ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 86,227

▲ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -373,585.

People and assets in 2025

Wage cost

€ 253,021

▲ 3% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 6,155

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 137,818

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 82,975

▲ 158% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 222,049 Gross margin 2022: € 222,049 First fiscal year in the series	€ 232,087 Gross margin 2023: € 232,087 ▲ 5% vs 2022 (€ 222,049) Favourable step	€ 294,557 Gross margin 2024: € 294,557 ▲ 27% vs 2023 (€ 232,087) Favourable step	€ 617,583 Gross margin 2025: € 617,583 ▲ 110% vs 2024 (€ 294,557) Favourable step	▲ 110%
Profit after taxes	€ -3,570 Profit after taxes 2022: € -3,570 First fiscal year in the series	€ -24,660 Profit after taxes 2023: € -24,660 ▼ € 21,090 vs 2022 (€ -3,570) Unfavourable step	€ 28,970 Profit after taxes 2024: € 28,970 ▲ € 53,630 vs 2023 (€ -24,660) Favourable step	€ 22,977 Profit after taxes 2025: € 22,977 ▼ 21% vs 2024 (€ 28,970) Unfavourable step	▼ 21%
Equity	€ -339,372 Equity 2022: € -339,372 First fiscal year in the series	€ -364,032 Equity 2023: € -364,032 ▼ € 24,660 vs 2022 (€ -339,372) Unfavourable step	€ -335,062 Equity 2024: € -335,062 ▲ € 28,970 vs 2023 (€ -364,032) Favourable step	€ -312,085 Equity 2025: € -312,085 ▲ € 22,977 vs 2024 (€ -335,062) Favourable step	▲ € 22,977
Total debts	€ 363,561 Total debts 2022: € 363,561 First fiscal year in the series	€ 442,951 Total debts 2023: € 442,951 ▲ 22% vs 2022 (€ 363,561) Unfavourable step	€ 439,009 Total debts 2024: € 439,009 ▼ 1% vs 2023 (€ 442,951) Favourable step	€ 779,697 Total debts 2025: € 779,697 ▲ 78% vs 2024 (€ 439,009) Unfavourable step	▲ 78%
Cash	€ 76,073 Cash 2022: € 76,073 First fiscal year in the series	€ 71,712 Cash 2023: € 71,712 ▼ 6% vs 2022 (€ 76,073) Unfavourable step	€ 63,453 Cash 2024: € 63,453 ▼ 12% vs 2023 (€ 71,712) Unfavourable step	€ 86,227 Cash 2025: € 86,227 ▲ 36% vs 2024 (€ 63,453) Favourable step	▲ 36%
Retained profit	€ -400,872 Retained profit 2022: € -400,872 First fiscal year in the series	€ -425,532 Retained profit 2023: € -425,532 ▼ € 24,660 vs 2022 (€ -400,872) Unfavourable step	€ -396,562 Retained profit 2024: € -396,562 ▲ € 28,970 vs 2023 (€ -425,532) Favourable step	€ -373,585 Retained profit 2025: € -373,585 ▲ € 22,977 vs 2024 (€ -396,562) Favourable step	▲ € 22,977
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 6,155 Bank debt 2025: € 6,155 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 315,121 Balance sheet total 2022: € 315,121 First fiscal year in the series	€ 369,852 Balance sheet total 2023: € 369,852 ▲ 17% vs 2022 (€ 315,121) Unchanged	€ 394,880 Balance sheet total 2024: € 394,880 ▲ 7% vs 2023 (€ 369,852) Unchanged	€ 467,613 Balance sheet total 2025: € 467,613 ▲ 18% vs 2024 (€ 394,880) Unchanged	▲ 18%
Employees (FTE)	-	4.7 Employees (FTE) 2023: 4.7 First fiscal year in the series	-	-

Key figures of PHARMACIE CENTRALE DE BRAINE L'ALLEUD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE CENTRALE DE BRAINE L'ALLEUD?

What happened at PHARMACIE CENTRALE DE BRAINE L'ALLEUD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 22,977 (▼ 21% vs 2024). filed late Source: NBB ↗
2026 Jean-Philippe Leroy stepped down as director. NBB
2026 ORELYS SRL stepped down as director. NBB
2020 Jean-Philippe Leroy became a director. NBB
2020 ORELYS SRL became a director. NBB
Nov 7, 1990 New establishment in Braine-l'Alleud. KBO
Oct 16, 1989 Start of the company according to the CBE. KBO

In short

From € 3,570 loss in 2022 to € 22,977 profit in 2025.

Paid € 171,294 in corporate taxes since 2022.

Best year ever: 2024, with € 28,970 profit.

On average € 49,400 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Jean-Philippe Leroy

Director

Also active at: Les Pharmacies de Gare, FARGAN, LEARGEST, PHARMA 5, ORELYS

since 2020 · until 2026

ORELYS SRL

Managing director · represented by Virginie Delvaulx

Also active at: Les Pharmacies de Gare, PACHECO, FARGAN, LEARGEST

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Léon Jourez 2

1420 Braine-l'Alleud

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

LEARGEST same network

€ 213,207 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0438.709.422

VAT number

BE 0438.709.422

Registered office

Avenue Léon Jourez 2, 1420 Braine-l'Alleud

Names & denominations

PHARMACIE CENTRALE DE BRAINE L'ALLEUD

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

16 October 1989

Peppol

Active · Active since 16 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗